By Leah Concialdi Photos by Brian Greenblatt and Joseph Baura As a mysterious synth tone filled the air, Lettuce commenced their set with "Trapezoid," the lead track off of their 2019 GRAMMY-nominated ...
Eli Lilly said on Tuesday it cut the price for vials of its weight-loss drug Zepbound by $50 or more and expanded the range ...
Hims & Hers Health shares were headed for their biggest single-day plunge as Wall Street analysts questioned the telehealth ...
Bank of Portugal Governor Mario Centeno said he would like to have more banks listed on the country’s stock market.
Eli Lilly stock surges past $840, outperforming the S&P 500. Click here to learn why LLY stock is still undervalued and why ...
Hims & Hers projects $725M in GLP-1 weight loss revenue for 2025, a 3.2x increase from 2024. Read why I upgrade HIMS stock ...
Investing.com - Hims & Hers said on Monday that it may stop selling legal copies of a popular weight-loss drug made by Denmark's Novo Nordisk (NYSE: NVO), sending shares in the U.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results